Stryker cuts ties with Corin Group amid two new distribution deals
Stryker Corp.’s (NYSE:SYK) orthopedics division cut distribution ties with Corin Group plc (LON:CRG), citing changing market opportunities and changing ownership of Stryker’s metal-on-metal hip device...
View ArticleStryker sales drop 3 percent, shares follow
Stryker Corp.’s (NYSE:SYK) second-quarter sales slid more than 3 percent, despite a top-line rise of 16.3 percent, as the Kalamazoo, Mich.-based medical device maker digested a pair of big...
View ArticleStryker reaches deep into pockets for 2011 acquisitions
Stryker Corp.’s (NYSE:SYK) coffers look significantly thinner these days, after the company blew through about 71 percent of its cash and cash equivalents during the first half of 2011 on acquisitions....
View ArticleUnsuccessful Stryker brain stent shows flaws in device development, approval
A federal study of a new stent designed to prevent repeat strokes was stopped early because 2 1/2 times (14.7%) more people either died or had a repeat stroke after receiving the stent than those who...
View ArticleSynthes suit accuses Stryker of stealing trade secrets
Synthes is back in court, this time as the plaintiff in a lawsuit against Stryker Corp. (NYSE: SYK) accusing the Michigan-based medical device company of trying to obtain “an improper competitive...
View ArticleACA’s 2013 medical device tax has already killed jobs, expansion plans
The Patient Protection and Affordable Care Act (ACA) includes a new 2.3% tax on the U.S. sale of medical devices beginning in 2013. The tax was included to raise $20 billion in revenue to partially...
View ArticleSmart orthopedic implants, devices on the way as OrthoSensor secures $15M
Talk about convergence. A health company that’s working in the implantable devices, surgical devices and […]
View ArticleFDA places limits on Stryker’s Wingspan brain stent system out of fear of...
UPDATE: Stryker has provided a response to the FDA decision: Stryker is pleased to […]
View ArticleStryker announces FDA approval of clot removal device to treat ischemic stroke
Stryker announced Monday that the U.S. Food and Drug Administration has cleared a clot removal […]
View ArticleStryker recalls models of waste management product that did not have...
Stryker issued an urgent medical device recall notice Tuesday noting that it was expanding the […]
View ArticleStryker’s new CEO: Innovation teams now asking, “Who is going to pay for this?”
Just one month ago, Kevin Lobo took over the top spot at medical device maker […]
View ArticleStryker CEO says firm’s foot and ankle business is taking on likes of Wright...
The 75 direct sales force dedicated to boost Stryker’s (NYSE: SYK) foot and ankle business unit […]
View ArticleStryker mimics Medtronic in move to buy Chinese orthopedics maker for $764M
They say imitation is the best form of flattery. In announcing that it was buying […]
View ArticleZimmer scores 510(k) nod for device to aid surgeons with reverse arthroplasty...
Zimmer Holdings, Inc. (ZMH) may have gone down swinging in its most recent courtroom drama […]
View ArticleStryker to acquire MAKO Surgical Corp.
Stryker (SYK) will acquire MAKO Surgical Corp. to the tune of about $1.65 billion. “MAKO […]
View ArticleStryker’s OtisMed division fined $80M for distributing knee replacement...
Stryker Corp.’s OtisMed unit will pay $80 million in fines because the division distributed its knee […]
View ArticleMedtronic named best place to work in medical sales in 2015
MedReps.com surveyed 1,400 members of the site’s community, who currently work or recently worked in […]
View ArticleHow does Stryker view the future of neurotechnology? CEO Kevin Lobo provides...
Neurotechnology, mobility and robotics are the main focuses for Stryker moving forward.
View ArticleStryker inks $1.28B deal for automated external defibrillator maker...
Washington-based Physio-Control will be integrated into Stryker’s emergency medical systems portfolio.
View ArticleStryker is offering a $5M guarantee for its surgical sponges – designed so...
The SurgiCount product has been available for years, but Stryker is now standing by its product in a unique and perhaps rarely confident way. The device company is calling it the SurgiCount Promise.
View ArticleFrom devices to data, Stryker charts smart evolution
Smart medtech companies are realizing that they have to be partners to hospitals and not simply vendors selling widgets.
View ArticleOn telemedicine, Zimmer Biomet and Stryker have stark contrast
Zimmer Biomet just acquired a telerehab startup, RespondWell, to play in a different part of the bundle as it relates to the Comprehensive Care for Joint Replacement program for hip and knee...
View ArticleStryker launches expensive Mako robot for knee replacement in cost-conscious era
Stryker is launching its Triathlon total knee on its Mako robotic system, reportedly priced at $1 million, at a time of bundled payments and cost consciousness in joint replacement procedures.
View ArticleThe robotic have-not: How J&J plans to woo hospitals, knee surgeons
As the buzz around robotics grows, J&J ‘s DePuy Synthes is touting the clinical and economic evidence tied to its non-robotic knee platform to help hospitals navigate the bundled payments era, but...
View ArticleThe biggest takeaway from the annual meeting of orthopedic surgeons (AAOS)
The shift from volume to value is no where more apparent than in the orthopedics specialty where vendors that once obsessed over titanium and steel are now focusing on services to manage the bundled...
View ArticleHow VR can improve OR efficiency
Orthopedics heavyweight Stryker is leveraging Microsoft’s Microsoft HoloLens holographic technology to reimagine the operating room and bring efficiencies to hospitals.
View ArticleStryker buys Canadian imaging technology firm for $701M
Stryker is shelling out top dollar to buy Novadaq, a maker of fluorescence imaging technologies that allows surgeons to see blood flow in vessels during surgery in real time.
View ArticleStryker aims to boost flagging spine division with $1.4B acquisition of K2M
Analysts say that Stryker’s purchase of a small but fast-growing public company in the complex spine market should help its own struggling spine business.
View ArticleStryker picks up OrthoSpace for up to $220 million in payments
The acquisition price for the Israeli company was $110 million in upfront cash payments with the potential for an additional $110 million upon meeting certain commercial milestones.
View ArticleAnalyst: Latest Stryker deal is more than “just another tuck-in acquisition”
Don’t mistake Stryker’s latest $500 million deal in the spine market as a simple tuck-in acquisition, says one analyst while another says it could help Stryker give Medtronic a run for its money.
View Article
More Pages to Explore .....